# Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma

> **NCT03899740** · — · UNKNOWN · sponsor: **Association Jean Baptiste Desbrest** · enrollment: 30 (estimated)

## Conditions studied

- Asthma

## Interventions

- **OTHER:** Brainstorming 1
- **OTHER:** Ranking - Round 1
- **OTHER:** Ranking - Round 2
- **OTHER:** Ranking - Round 3

## Key facts

- **NCT ID:** NCT03899740
- **Lead sponsor:** Association Jean Baptiste Desbrest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2019-09-26
- **Final completion:** 2019-09-26
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-09-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899740, "Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03899740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*